成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 41060-15-5 Chemical Structure| 41060-15-5
Chemical Structure| 41060-15-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 41060-15-5

,{[proInfo.pro_purity]}

Neobavaisoflavone, an isoflavone isolated from the seeds of Psoralea corylifolia, has striking anti-inflammatory and anti-cancer effects.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of [ Neobavaisoflavone ]

CAS No. :41060-15-5
Formula : C20H18O4
M.W : 322.35
SMILES Code : O=C1C(C2=CC=C(O)C(C/C=C(C)\C)=C2)=COC3=CC(O)=CC=C13
MDL No. :MFCD00800660
InChI Key :OBGPEBYHGIUFBN-UHFFFAOYSA-N
Pubchem ID :5320053

Safety of [ Neobavaisoflavone ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of [ Neobavaisoflavone ]

DNA
RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description Reference
RAW264.7 macrophages 1–100 μM 20 h Neobavaisoflavone significantly inhibited the production of ROS, RNS, and cytokines (IL-1β, IL-6, IL-12p40, IL-12p70, TNF-α) in LPS+IFN-γ or PMA-stimulated RAW264.7 macrophages PMC6263287
MC3T3-E1 cells 0.01, 0.05, 0.25, 1 mM 1, 3, 7 days To evaluate the cytocompatibility of hydrogels with MC3T3-E1 cells, results showed that the hydrogels were non-toxic to the cells and supported good cell growth. PMC11803222
BV-2 microglia cells 50 μM 24 h Inhibition of LPS-induced NO production PMC6274380
rat liver microsome 0.1 mg/mL 5, 10, 15, 30, 45, 60, 120, and 240 min To study the metabolites of Neobavaisoflavone in rat liver microsome PMC9736981
U-87 MG glioblastoma cells 25 μM 48 h To investigate the effect of NBIF in combination with doxorubicin or etoposide on apoptosis, results showed that NBIF enhanced the pro-apoptotic activity of both drugs. PMC9144651
Normal human astrocytes 25 μM 48 h To investigate the effect of NBIF in combination with doxorubicin or etoposide on apoptosis, results showed that NBIF enhanced the pro-apoptotic activity of both drugs. PMC9144651
primary hepatocytes 0.2 μg/ml 24 h Neobavaisoflavone ameliorates hepatocyte injury, relieves oxidative stress, and downregulates the PKC-α/NOX signaling pathway. PMC7025552

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
rats normal rats oral 150 mg/kg 3 consecutive days To study the metabolites of Neobavaisoflavone in rats PMC9736981

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.10mL

0.62mL

0.31mL

15.51mL

3.10mL

1.55mL

31.02mL

6.20mL

3.10mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories